Rhythm Biosciences Limited (FRA:0RY)

Germany flag Germany · Delayed Price · Currency is EUR
0.0505
-0.0020 (-3.81%)
Last updated: Oct 21, 2025, 9:59 AM CET
-3.81%
Market Cap17.15M
Revenue (ttm)1.78M
Net Income (ttm)-2.14M
Shares Outn/a
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0505
Previous Close0.0525
Day's Range0.0505 - 0.0505
52-Week Range0.0270 - 0.0825
Betan/a
RSI52.41
Earnings DateAug 29, 2025

About Rhythm Biosciences

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2017
Country Australia
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 0RY
Full Company Profile

Financial Performance

In 2025, Rhythm Biosciences's revenue was 3.19 million, an increase of 88.85% compared to the previous year's 1.69 million. Losses were -3.83 million, -44.15% less than in 2024.

Financial numbers in AUD Financial Statements

News

There is no news available yet.